SWOG clinical trial number
SWOG-8748
Alternating Induction Chemotherapy with Weekly Adriamycin and 5-Fluorouracil/Leucovorin Followed by Adriamycin and Cyclophosphamide, a Phase II Study in Poor Risk, Stage IV Breast Cancer
Closed
Phase
Accrual
77%
Published
Abbreviated Title
Alternating Induction Chemotherapy with Weekly Adriamycin and 5-Fluorouracil/Leucovorin Followed by Adriamycin and Cyclophosphamide, a Phase II Study in Poor Risk, Stage IV Breast Cancer
Activated
07/15/1988
Closed
03/01/1990
Publication Information Expand/Collapse
1991
Alternating weekly doxorubicin and 5-fluorouracil/leucovorin followed by weekly doxorubicin and daily cyclophosphamide in stage IV breast cancer. A Southwest Oncology Group study.